ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease

Wu, Tingfeng; Ye, Junzhao; Gong, Xiaorong; Li, Xin; Shao, Congxiang; Li, Fuxi; Lin, Yansong; Ma, Qianqian; Mai, Weiyi; Wang, Wei; Feng, Shi-Ting; Zhong, Bihui*广州医学院; 南方医科大学; 中山大学; 1; 东莞市人民医院
Digestive and Liver Disease2021-12DOI: 10.1016/j.dld.2021.02.003
5被引17阅读
引用收藏
分享

摘要

Background: Advanced Non-alcoholic fatty liver disease (NAFLD) is associated with increased risk of cardiovascular disease (CVD). Aim: We determine whether combinations of ultrasound graphic steatosis grades, fibrosis scores and apolipoprotein levels add value to CVD risk prediction in NAFLD patients. Methods: The retrospective cohort study enrolled 10,453 individuals (3519 NAFLD; 6934 non NAFLD) from 2004 to 2018. Hepatic ultrasound measurements, lipid and apolipoprotein profiles, Fibrosis-4 and the NAFLD fibrosis scores (NFS) were assessed. The primary outcome included both clinical and subclinical CVD. Results: During 116-month follow-up period, there were 957 clinical and 752 subclinical CVD events. NAFLD patients had a higher incidence of CVD than non NAFLD patients as the steatosis degree, NFS, and FIB4 scores increased (25.1% vs 11.9%, Log Rank: p < 0.001). For the lipid and apolipoprotein profiles excluding triglyceride or ApoE, subjects with varied steatosis severity in the upper two tertiles had different risk of CVD ( p for interaction < 0.001). A nomogram model combination of Framingham Risk Score (FRS), NFS and apolipoprotein profiles presented a higher AUC than FRS in a time-dependent ROC curve (0.816 vs 0.752, p < 0.001). Conclusion: The novel risk score considering ultrasonography-defined steatosis grades, non-invasive liver fibrosis scores and apolipoprotein profiles accurately predicted the 10-year risk of CVD.

学科与关键词

关键词
ApolipoproteinLiver steatosisNAFLD fibrosis scoresPredictionRisk stratification
相关
加载中…
  • Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank
    Ma, Wen; Wu, Wentao; Wen, Weixing; Xu, Fengshuo; Han, Didi; Lyu, Jun*; Huang, Yuli*Therapeutic Advances in Chronic Disease, 2022, 13.被引 8
  • The association of non-alcoholic fatty liver disease and advanced hepatic fibrosis with cardiovascular mortality in Taiwanese adults: a longitudinal cohort study
    Wei, X.; Yu, T.; Bo, Y.; Ho, K.; Lao, X.Annual Meeting of the European-Society-of-Cardiology (ESC), Amsterdam, NETHERLANDS, 2023-08-25 To 2023-08-28.
  • Associations of Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease With Cardiovascular Healthy Outcomes
    Wu, Wentao; Ma, Wen; Yuan, Shiqi; Feng, Aozi; Li, Li; Zheng, Haoxiao; Li, Shuna; He, Ningxia; Huang, Yuli*; Lyu, Jun*Journal of the American Heart Association, 2023, 12(23): e031440.
查看全部 →

发表信息

论文状态
公开发表
期刊
Digestive and Liver Disease
发表日期
2021-12
卷期
第 53 卷, 第 12 期
页码
1610-1619
DOI
10.1016/j.dld.2021.02.003
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81870404, 81670518, 81170392]

作者

  • W

    Wu, Tingfeng (第一作者)

    1 · 2 · sun yat sen univ

  • Y

    Ye, Junzhao

    1 · 2 · sun yat sen univ

查看全部 12 位作者收起作者
  • G

    Gong, Xiaorong

    1 · guangzhou med univ

  • L

    Li, Xin

    dongguan peoples hosp · southern med univ

  • S

    Shao, Congxiang

    1 · 2 · sun yat sen univ

  • L

    Li, Fuxi

    1 · 2 · sun yat sen univ

  • L

    Lin, Yansong

    1 · 2 · sun yat sen univ

  • M

    Ma, Qianqian

    1 · 2 · sun yat sen univ

  • M

    Mai, Weiyi

    1 · 2 · sun yat sen univ

  • W

    Wang, Wei

    1 · 2 · sun yat sen univ

  • F

    Feng, Shi-Ting

    1 · 2 · sun yat sen univ

  • Z

    Zhong, Bihui (通讯)

    1 · 2 · sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417